Myriad Genetics Investors: Filing Deadline in MYGN Class Action Approaches – Contact Lieff Cabraser

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser

Lieff Cabraser reminds investors that securities fraud class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN) between September 2, 2016 and August 13, 2019, inclusive (the “Class Period”). [Read more…]

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action – Contact Lieff Cabraser

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ:MYGN) between September 2, 2016 and August 13, 2019, inclusive (the “Class Period”). [Read more…]